Integral Diagnostics Limited (ASX:IDX – Get Free Report) insider Ian Kadish bought 25,000 shares of Integral Diagnostics stock in a transaction dated Wednesday, March 5th. The stock was purchased at an average price of A$2.16 ($1.36) per share, with a total value of A$53,950.00 ($33,930.82).
Integral Diagnostics Price Performance
The company has a debt-to-equity ratio of 118.59, a current ratio of 0.86 and a quick ratio of 1.84. The firm has a market capitalization of $1.10 billion, a PE ratio of -11.45, a P/E/G ratio of 1.39 and a beta of 0.73.
Integral Diagnostics Dividend Announcement
The company also recently announced a Interim dividend, which will be paid on Sunday, April 6th. Investors of record on Sunday, April 6th will be issued a $0.025 dividend. This represents a dividend yield of 1.06%. The ex-dividend date of this dividend is Wednesday, March 5th. Integral Diagnostics’s dividend payout ratio is currently -23.08%.
Integral Diagnostics Company Profile
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.
Featured Stories
- Five stocks we like better than Integral Diagnostics
- Industrial Products Stocks Investing
- Is Myers Industries Poised for a Breakout?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- What Investors Need to Know About Upcoming IPOs
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Receive News & Ratings for Integral Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.